Abstract

This study was designed to evaluate the prophylactic action of RU-41740 (‘Biostim’) on upper respiratory tract (URT) infections in a group of children with mild cystic fibrosis. RU-41740 is an immunomodulator of biological origin used against recurrent respiratory infections in adults and children over 1 year of age.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.